<DOC>
	<DOCNO>NCT00429988</DOCNO>
	<brief_summary>RATIONALE : Collecting sample fluid use ductal lavage nipple aspiration participant high risk breast cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This clinical trial use ductal lavage collect fluid woman high risk breast cancer .</brief_summary>
	<brief_title>Study Ductal Lavage Women High Risk Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine volume atypical cell collect ductal lavage woman increase risk breast cancer . Secondary - Determine assay technique analyze nipple aspirate fluid ductal lavage fluid sample participant . - Analyze nipple aspirate fluid participant specific global protein signature . - Determine replicability marker serial assays participant . - Determine percentage participant atypia ductal lavage ductal lesion identify use ductoscopy . OUTLINE : This multicenter study . Participants undergo nipple aspirate fluid ductal lavage fluid collection . Fluid sample analyze use cytological analysis , immunohistochemistry , fluorescent situ hybridization , situ polymerase chain reaction . Protein pattern identify use mass spectrometry . Participants find atypia undergo repeat lavage 3-6 month 1 year . Participants normal fluid sample undergo repeat lavage 1 year . PROJECTED ACCRUAL : A total 30 participant accrue study within 2-3 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : High risk breast cancer define 1 following : History atypical hyperplasia atypia find biopsy , fineneedle aspiration , ductal lavage Family history cancer meeting least 1 follow criterion : Single relative multiple primary cancer One relative 40 year age breast cancer OR bilateral breast cancer Two relative ovarian cancer Two relative breast cancer 1 50 year age One relative breast cancer plus â‰¥ 1 relative ovarian cancer Ashkenazi Jewish descent AND relative breast cancer 50 year age OR ovarian cancer age BRCA1 and/or BRCA2 mutation Prior breast cancer contralateral breast Gail risk &gt; 1.7 % Spontaneous nipple discharge Serum estradiol &gt; 10 pmol/L Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age Over 18 Sex Female Menopausal status Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Able obtain breast duct fluid PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy More 4 month since prior tamoxifen raloxifene Radiotherapy No prior radiotherapy breast Surgery No prior incisional excisional biopsy within 1.5 cm nipple Other No prior neoadjuvant therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>breast cancer</keyword>
</DOC>